Chiral phase-transfer catalyst and method for preparing alpha-amino acid by using the same

US10696621B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10696621-B2
Application numberUS-201716302618-A
CountryUS
Kind codeB2
Filing dateFeb 6, 2017
Priority dateMay 19, 2016
Publication dateJun 30, 2020
Grant dateJun 30, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a novel chiral phase-transfer catalyst, and a method for preparing an alpha-amino acid by using the same. According to the present invention, an alpha-amino acid of high optical purity could be synthesized in a high yield under an easy industrially applicable reaction condition by using a novel cinchona alkaloid compound as a chiral phase-transfer catalyst, and thus the present invention can be used as a key technique of the asymmetric alpha-amino acid synthesis and preparation field.

First claim

Opening claim text (preview).

What is claimed is: 1. A cinchona-alkaloid compound of Formula 1 below: wherein, X is selected from the group consisting of —CH 2 —, —C(OH)H—, —C(═O)—, —O—, —S—, and —S(═O)—; R is R 1 is selected from the group consisting of hydrogen, C 1 to C 10 alkyl, and C 1 to C 5 alkoxy; R 2 is vinyl or ethyl; R 3 is selected from the group consisting of hydrogen, C 1 to C 10 alkyl, allyl, C 5 to C 10 aryl, naphthalen-1-yl-methyl, and anthracen-9-yl-methyl; and Y − is selected from the group consisting of: halogen anion of fluoride, chloride, bromide, and iodide, IO 4 − , ClO 4 − , R 4 SO 3 − , trifluoromethane sulfonate (OTf − ) and HSO 4 − , wherein R 4 is C 1 -C 4 alkyl or C 5 -C 0 aryl. 2. The compound according to claim 1 , wherein said X of the compound of Formula 1 is one of —CH 2 —, —C(OH)H— or —C(═O)—, wherein R 1 is hydrogen or C 1 to C 5 alkoxy; R 2 is vinyl or ethyl; R 3 is hydrogen, C 1 to C 10 alkyl, allyl, or C 5 to C 10 aryl; and Y − is halogen anion selected from the group consisting of fluorine, chlorine, bromine, and iodine. 3. The compound according to claim 1 , wherein said X of the compound of Formula 1 is —CH 2 —, —C(OH)H— or —C(═O)—, wherein R 1 is hydrogen or methoxy group; R 2 is vinyl or ethyl group; R 3 is hydrogen or allyl group; and Y − is halogen anion selected from the group consisting of fluoride, chloride, bromide, and iodide. 4. The compound according to claim 3 , wherein said compound is selected from the group consisting of: 4,4′-bis(cinchonidium-N-methyl)biphenyl methanone dibromide; 4,4′-bis(O(9)-allylcinchonidium-N-methyl)biphenyl methanone dibromide; 4,4′-bis(hydrocinchonidium-N-methyl)biphenyl methanone dibromide; 4,4′-bis(O(9)-allylhydrocinchonidium-N-methyl)biphenyl methanone dibromide; 3,4′-bis(cinchonidium-N-methyl)biphenyl methanone dibromide; 3,4′-bis(O(9)-allylcinchonidium-N-methyl)biphenyl methanone dibromide; 3,3′-bis(cinchonidium-N-methyl)biphenyl methanone dibromide; 3,3′-bis(O(9)-allylcinchonidium-N-methyl)biphenyl methanone dibromide; 4,4′-bis(cinchonidium-N-methyl)biphenyl methane dibromide; 4,4′-bis(O(9)-allylcinchonidium-N-methyl)biphenyl methane dibromide; 4,4′-bis(hydrocinchonidium-N-methyl)biphenyl methane dibromide, 4,4′-bis(O(9)-allylhydrocinchonidium-N-methyl)biphenyl methane dibromide; 4,4′-bis(quinium-N-methyl)biphenyl methane dibromide; 4,4′-bis(O(9)-allylquinium-N-methyl)biphenyl methane dibromide; 4,4′-bis(cinchonidium-N-methyl)biphenyl methanol dibromide; 4,4′-bis(O(9)-allylcinchonidium-N-methyl)biphenyl methanol dibromide, 4,4′-bis(hydrocinchonidium-N-methyl)biphenyl methanol dibromide; 4,4′-bis(O(9)-allylhydrocinchonidium-N-methyl)biphenyl methanol dibromide, 4,4′-bis(cinchonium-N-methyl)biphenyl methanone dibromide, 4,4′-bis(O(9)-allylcinchonium-N-methyl)biphenyl methanone dibromide, 4,4′-bis(cinchonium-N-methyl)biphenyl methane dibromide, 4,4′-bis(O(9)-allylcinchonium-N-methyl)biphenyl methane dibromide; 4,4′-bis(quinidium-N-methyl)biphenyl methane dibromide; 4,4′-bis(O(9)-allylquinidium-N-methyl)biphenyl methane dibromide; 4,4′-bis(cinchonium-N-methyl)biphenyl methanol dibromide; and 4,4′-bis(O(9)-allylcinchonium-N-methyl)biphenyl methanol dibromide. 5. The compound according to claim 1 , wherein said X of the compound of Formula 1 is —O—, —S— or —S(═O)—, wherein R 1 is hydrogen or C 1 -C 5 alkoxy; R 2 is vinyl or ethyl; R 3 is hydrogen, C 1 -C 10 alkyl, allyl, or C 5 -C 10 aryl; and Y − is halogen anion selected from the group consisting of fluorine, chlorine, bromine, and iodine. 6. The compound according to claim 1 , wherein said X of the compound of Formula 1 is —O—, —S— or —S(═O)—, wherein R 1 is hydrogen or methoxy; R 2 is vinyl or ethyl; R 3 is hydrogen, allyl, or benzyl; and Y − is halogen anion selected from the group consisting of fluorine, chlorine, bromine, and iodine. 7. The compound according to claim 6 , wherein said compound is selected from the group consisting of: 4,4′-bis(cinchonidium-N-methyl)biphenyl ether dibromide; 4,4′-bis(O(9)-allylcinchonidium-N-methyl)biphenyl ether dibromide; 4,4′-bis(O(9)-benzyl-cinchonidium-N-methyl)biphenyl ether dibromide; 4,4′-bis(hydrocinchonidium-N-methyl)biphenyl ether dibromide; 4,4′-bis(O(9)-allylhydrocinchonidium-N-methyl)biphenyl ether dibromide; 4,4′-bis(quinium-N-methyl)biphenyl ether dibromide; 4,4′-bis(O(9)-allylquinium-N-methyl)biphenyl ether dibromide; 3,3′-bis(cinchonidium-N-methyl)biphenyl ether dibromide; 3,3′-bis(O(9)-allylcinchonidium-N-methyl)biphenyl ether dibromide; 4,4′-bis(cinchonidium-N-methyl)biphenyl thioether dibromide; 4,4′-bis(O(9)-allylcinchonidium-N-methyl)biphenyl thioether dibromide; 4,4′-bis(hydrocinchonidium-N-methyl)biphenyl thioether dibromide; 4,4′-bis(O(9)-allylhydrocinchonidium-N-methyl)biphenyl thioether dibromide; 4,4′-bis(quinium-N-methyl)biphenyl thioether dibromide; 4,4′-bis(O(9)-allylquinium-N-methyl)biphenyl thioether dibromide; 3,3′-bis(cinchonidium-N-methyl)biphenyl sulfide dibromide; 3,3′-bis(O(9)-allylcinchonidium-N-methyl)biphenyl sulfide dibromide; 4,4′-bis(cinchonidium-N-methyl)biphenyl sulfoxide dibromide; 4,4′-bis(O(9)-allylcinchonidium-N-methyl)biphenyl sulfoxide dibromide; 4,4′-bis(hydrocinchonidium-N-methyl)biphenyl sulfoxide dibromide; 4,4′-bis(O(9)-allylhydrocinchonidium-N-methyl)biphenyl sulfoxide dibromide; 4,4′-bis(cinchonium-N-methyl)biphenyl ether dibromide; 4,4′-bis(O(9)-allylcinchonium-N-methyl)biphenyl ether dibromide; 4,4′-bis(quinidium-N-methyl)biphenyl ether dibromide; 4,4′-bis(O(9)-allylquinidium-N-methyl)biphenyl ether dibromide; 4,4′-bis(cinchonium-N-methyl)biphenyl thioether dibromide; 4,4′-bis(O(9)-allylcinchonium-N-methyl)biphenyl thioether dibromide; 4,4′-bis(quinidium-N-methyl)biphenyl thioether dibromide; 4,4′-bis(cinchonium-N-methyl)biphenyl sulfoxide dibromide; and 4,4′-bis(O(9)-allylcinchonium-N-methyl)biphenyl sulfoxide dibromide.

Assignees

Inventors

Classifications

  • Quaternary ammonium compounds · CPC title

  • C07D453/04Primary

    having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine · CPC title

  • containing organic compounds or metal hydrides · CPC title

  • C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type · CPC title

  • Ortho-condensed systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10696621B2 cover?
The present invention relates to a novel chiral phase-transfer catalyst, and a method for preparing an alpha-amino acid by using the same. According to the present invention, an alpha-amino acid of high optical purity could be synthesized in a high yield under an easy industrially applicable reaction condition by using a novel cinchona alkaloid compound as a chiral phase-transfer catalyst, and …
Who is the assignee on this patent?
Univ Yeungnam Res Cooperation Foundation
What technology area does this patent fall under?
Primary CPC classification B01J31/0239. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).